Skip to main content

Day: July 19, 2023

Magnetic Resonance Imaging Market to Worth USD 9 Billion by 2030 | Skyquest Technology

Magnetic resonance imaging is segmented based on the architecture, field strength. Based on architecture, the market is segmented into closed MRI systems, standard bore MRI, wide bore MRI and open MRI systems. Based on field strength, the market is segmented into low-field strength, mid-field strength and high-field strength- Industry Forecast 2023-2030 Westford,USA, July 19, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the magnetic resonance imaging market is witnessing significant growth, primarily driven by the increasing prevalence of chronic and serious diseases worldwide. In today’s medical landscape, there has been a consistent rise in the incidence of various severe and chronic illnesses, necessitating a higher demand for advanced medical imaging technologies. Browse in-depth TOC on the “Magnetic Resonance...

Continue reading

Edible Garden Introduces GreenThumb 2.0 Patented, Proprietary Greenhouse Management Software

Enhanced Tool Provides Dynamic Forecasting and Efficient Data Integration Provides Enhanced Ability to Manage Costs BELVIDERE, NJ, July 19, 2023 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce and products, today announced the launch of GreenThumb 2.0, an enhanced version of the Company’s proprietary, cloud-based, GreenThumb greenhouse management and demand planning system, which provides the ability to manage goods throughout the entire supply chain. Mr. Jim Kras, Chief Executive Officer of Edible Garden, stated, “I am pleased to announce the launch of GreenThumb 2.0, the next generation of our advanced, state-of-the-art, greenhouse management system. With an improved degree...

Continue reading

Plumas Bancorp Reports Record 2023 Earnings

RENO, Nev., July 19, 2023 (GLOBE NEWSWIRE) — Plumas Bancorp (Nasdaq:PLBC), the parent company of Plumas Bank, today announced earnings during the second quarter of 2023 of $6.7 million or $1.14 per share, an increase of $1.0 million from $5.7 million or $0.97 per share during the second quarter of 2022. Diluted earnings per share increased to $1.12 per share during the three months ended June 30, 2023 up from $0.96 per share during the quarter ended June 30, 2022. For the six months ended June 30, 2023, the Company reported net income of $14.3 million or $2.44 per share, an increase of $2.9 million from $11.4 million or $1.95 per share earned during the six months ended June 30, 2022. Earnings per diluted share increased to $2.41 during the six months ended June 30, 2023 up $0.48 from $1.93 during the first six months of 2022....

Continue reading

HeartSciences Provides Business Update and Reports Fiscal 2023 Financial Results

Southlake, Texas, July 19, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today provided a business update and reported financial results for the fiscal year ended April 30, 2023. Key milestones during Fiscal 2023 and to date:Completed patient enrollment for the MyoVista® wavECGTM multi-center pivotal study; on track for FDA submission later in the year; Further expansion of the IP portfolio in the US and internationally, bringing the total number of granted patents to 40;US patent granted for the use of AI to create key echocardiographic heart measures; Korean and Israeli patents granted...

Continue reading

Mushrooms Inc. CEO, Kimberly Carlson, Discusses Exciting Potential of Industrial Mushroom Industry on Psychedelic Spotlight Podcast

ESTERO, Fla., July 19, 2023 (GLOBE NEWSWIRE) — via IBN — Mushrooms Inc. (OTC: MSRM) (the “Company” or “MSRM) is pleased to announce that its CEO, Kimberly Carlson, recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting potential of the industrial mushroom industry. As the first company trading on the US stock market focused on the industrial side of mushrooms, Mushrooms Inc. is leading the way in revolutionizing this emerging sector. To watch or listen to the complete interview featuring Kimberly Carlson on Psychedelic Spotlight, please visit the following link: https://psychedelicspotlight.com/using-mycelium-for-a-sustainable-future-feat-kimberly-carlson/ During the podcast episode hosted by David Flores (CEO of Psychedelic Spotlight), Kimberly Carlson shared insights into...

Continue reading

Zero Turn Mowers Market Set to Soar Past USD 1850 Billion by 2030 | Skyquest Technology

In the realm of zero turn mowers, the industry showcases varying sizes categorized by cutting width, ranging from under 50 inches to over 60 inches. These mowers derive power from gas, diesel, or electric sources, with horsepower options spanning low, medium, and high ranges. Yard space considerations include small, medium, and large areas, while applications encompass both residential and commercial usage. Distribution channels encompass direct and indirect sales. The industry is poised for substantial growth from 2023 to 2030. Westford USA, July 19, 2023 (GLOBE NEWSWIRE) — The global Zero Turn Mowers market size is expected to reach USD 1850 billion by 2030 and exhibit a CAGR of 7.2% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing demand for efficient and time-saving lawn...

Continue reading

Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans

Policy Updates Impact Nationwide Commercial Plans for 16.8 Million Covered Lives MALVERN, Pa., July 19, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced a healthcare policy update from Aetna increases access for patients to the Company’s NeuroStar® Advanced Therapy. Effective immediately, Aetna now allows transcranial magnetic stimulation (TMS) treatment to be ordered and conducted under the supervision of behavioral health nurse practitioners for patients with major depressive disorder (MDD). Also included in the update is the removal of a four-month psychotherapy trial before a patient becomes eligible to receive an...

Continue reading

Brera Holdings Announces South American Football Market Study Targeting Two Key Countries of Interest

Brera evaluates its “Social Impact through Sports” path on a new continentBrera will evaluate the South American football market Brera will evaluate the South American football marketDUBLIN and MILAN, July 19, 2023 (GLOBE NEWSWIRE) — Brera Holdings PLC (“Brera Holdings”, “Brera”, or the “Company”) (Nasdaq: BREA) announced that it has signed an agreement for a market study of South American football (the “Study”), centered on two countries of interest. The Study is expected to be completed within 60 days and focus primarily, though not exclusively, on the countries of Chile and Uruguay, as recommended by Fenix SpA (“Fenix”), the Company’s regional advisors and the Study’s authors.  This represents Brera Holding’s first potential foray into the richly talented South American market, home to 10 World Cup...

Continue reading

Conduent to Report Second-Quarter 2023 Financial Results on Aug. 2, 2023

FLORHAM PARK, N.J., July 19, 2023 (GLOBE NEWSWIRE) — Conduent Incorporated (Nasdaq: CNDT), a global technology-led business solutions and services company, plans to report its second-quarter 2023 financial results on Wednesday, Aug. 2 prior to market open. Management will present the results during a conference call and webcast at 9:00 a.m. ET. The call will be available by live audio cast along with the news release and online presentation slides at https://investor.conduent.com. The conference call will also be available by calling 877-407-4019 toll free. If requested, the conference ID is 13739455. The international dial-in is +1 201-689-8337. The international conference ID is also 13739455. A recording of the conference call will be available by calling 877-660-6853 three hours after the conference call concludes. The access...

Continue reading

Update on the Regulatory Approvals of the Tender Offer: GF Announced Expiration of U.S. Hart-Scott-Rodino Waiting period

Uponor Corporation, Stock Exchange Release, 19 July 2023 at 15.00 EET Update on the Regulatory Approvals of the Tender Offer: GF Announced Expiration of U.S. Hart-Scott-Rodino Waiting Period NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. As announced on 22 June 2023, Georg Fischer has commenced a voluntary recommended public cash tender offer for all the issued and outstanding shares in Uponor that are not held by Uponor or any of its subsidiaries. The offer period has commenced on 26 June 2023 and will expire preliminarily on September 1, 2023, at 4:00 p.m. (Finnish time), unless the offer period is extended, or any extended...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.